NCT05682235

Brief Summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to improve pain intensity.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 26, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 12, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2025

Completed
Last Updated

March 17, 2025

Status Verified

January 1, 2025

Enrollment Period

1.8 years

First QC Date

December 26, 2022

Last Update Submit

March 12, 2025

Conditions

Keywords

PainQuality of lifeChronic pelvic paintherapeutic exercisepain neurophysiologyphysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Changes in pain perception assessed using a 100mm Visual Analogue Scale (VAS)

    The scale will be administered by one of the researchers. Minimum value 0. Maximum value 100. Higher score = Higher level of pain. Lowe and lower scores mean a better result.

    Baseline, Up to 1 month, Up to 3 months

Secondary Outcomes (3)

  • Changes in Kinesiofobia assessed using the Tampa Scale of Kinesiofobia (TSK)

    Baseline, Up to 1 month, Up to 3 months

  • Changes in Catastrophism assesed using the Pain Catastrophism Scale (PCS)

    Baseline, Up to 1 month, Up to 3 months

  • Impression of the overall improvement obtained with the treatment ussing the Global rating of changes scale (GROC)

    Up to 6 months

Study Arms (2)

Therapeutic Exercise AND Pain Neurophysiology Education

EXPERIMENTAL

Therapeutic exercise: Therapeutic exercise is the systematic and planned execution of posture movements and physical activities to correct or prevent alterations, improve or enhance physical functioning, prevent risk factors for solid and optimize overall health status. Pain Neurophysiology Education: Education in pain neurophysiology consists in describing to the patient the neurobiology and neurophysiology of his nervous system pain to improve the processing of it and diminish the threatening meaning of pain.

Other: Therapeutic exercise AND pain neurophysiology education

Sham Comparator

SHAM COMPARATOR

Talks about healthy habits

Other: Sham

Interventions

A program of therapeutic exercise and education in the neurophysiology of pain will be applied to the participants of the experimental group and talks on healthy habits to the placebo group participants.

Therapeutic Exercise AND Pain Neurophysiology Education
ShamOTHER

Talk about healthy habits

Sham Comparator

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWoman
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women of reproductive age between 18 and 45 years.
  • Women with a medical diagnosis of endometriosis.
  • Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently.

You may not qualify if:

  • Women who must have surgery during the study.
  • Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months.
  • Women who are pregnant or planning a pregnancy.
  • Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities.
  • Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study.
  • Variations in medication in the 3 months prior to the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Valladolid

Valladolid, 47002, Spain

Location

MeSH Terms

Conditions

EndometriosisPain

Interventions

Exercise Therapysalicylhydroxamic acid

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Sandra Jímenez, Doctor

    University of Valladolid

    STUDY DIRECTOR
  • Luis Ceballos Laita, Doctor

    University Valladolid

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
the participants will not know in which treatment group they are, and the investigator in charge of carrying out the evaluation will not know to which group the subjects he evaluates belong to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Through a randomization program, participants will be assigned to the treatment group or the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctorate Student

Study Record Dates

First Submitted

December 26, 2022

First Posted

January 12, 2023

Study Start

December 12, 2022

Primary Completion

October 12, 2024

Study Completion

March 12, 2025

Last Updated

March 17, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

The data of the participants will only be kept by the study researchers.

Locations